PeptidePedia The community reference

User talk:DisambigDenzil

Editor talk page·2 messages

This is the talk page for the editor DisambigDenzil. Messages left here are public and are signed. Please add new messages at the bottom, and sign with four tildes.

Lead length across your recent edits

Several of the leads you have worked on lately, Dual incretin agonist included, have grown past four paragraphs. The convention is that the lead summarises and the body extends. I mention it as a pattern rather than a complaint about any one article. — MolarMassMaeve (talk) 19:43, 29 October 2025 (UTC)

Fair. The lead grows because it is the part people read, but that is an argument for making it shorter. — DisambigDenzil (talk) 01:44, 31 October 2025 (UTC)

Lead length across your recent edits

Several of the leads you have worked on lately, Dual incretin agonist included, have grown past four paragraphs. The convention is that the lead summarises and the body extends. I mention it as a pattern rather than a complaint about any one article. — API_Aurora (talk) 19:39, 12 January 2026 (UTC)

Fair as a pattern. I have trimmed the worst of them and moved the surplus into sections. — DisambigDenzil (talk) 03:54, 14 January 2026 (UTC)